ESOPJun 5, 2026, 05:06 PM
Petros Pharmaceuticals Grants 7M Restricted Shares to Officers & Directors
AI Summary
Petros Pharmaceuticals, Inc. announced that its Board of Directors approved the grant of an aggregate of 7,000,000 restricted shares of common stock to its Chairman, President and Chief Commercial Officer, and two directors. The awards, effective June 5, 2026, vest 50% immediately and the remaining 50% on the six-month anniversary, contingent on continued service. These awards were issued outside the company's 2020 Omnibus Incentive Compensation Plan.
Key Highlights
- Petros Pharmaceuticals granted 7,000,000 restricted shares to four key individuals.
- Chairman Joshua Silverman received 4,375,000 restricted shares.
- Director Bruce Bernstein received 1,875,000 restricted shares.
- President & CCO Fady Boctor received 375,000 restricted shares.
- Director Wayne Walker received 375,000 restricted shares.
- 50% of each award vested immediately on June 5, 2026.
- The remaining 50% will vest on the six-month anniversary of the grant date.
- Awards were issued outside the 2020 Omnibus Incentive Compensation Plan.
Price Impact
More from PTPI